98 related articles for article (PubMed ID: 2375645)
1. Axillary dissection in melanoma. Prognostic variables in node-positive patients.
Bevilacqua RG; Coit DG; Rogatko A; Younes RN; Brennan MF
Ann Surg; 1990 Aug; 212(2):125-31. PubMed ID: 2375645
[TBL] [Abstract][Full Text] [Related]
2. Melanoma with metastasis to regional axillary or inguinal lymph nodes: prognostic factors and results of surgical treatment in 714 patients.
Singletary SE; Shallenberger R; Guinee VF; McBride CM
South Med J; 1988 Jan; 81(1):5-9. PubMed ID: 3336801
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis.
Coit DG; Rogatko A; Brennan MF
Ann Surg; 1991 Nov; 214(5):627-36. PubMed ID: 1953117
[TBL] [Abstract][Full Text] [Related]
4. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma.
Galliot-Repkat C; Cailliod R; Trost O; Danino A; Collet E; Lambert D; Vabres P; Dalac S
Eur J Surg Oncol; 2006 Sep; 32(7):790-4. PubMed ID: 16822643
[TBL] [Abstract][Full Text] [Related]
6. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
7. [Axillar lymphadenectomy].
Oertli D
Chirurg; 2007 Mar; 78(3):194, 196-202. PubMed ID: 17310354
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of patients with pathologic stage II cutaneous malignant melanoma.
Roses DF; Provet JA; Harris MN; Gumport SL; Dubin N
Ann Surg; 1985 Jan; 201(1):103-7. PubMed ID: 3966826
[TBL] [Abstract][Full Text] [Related]
9. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma.
Egger ME; Brown RE; Roach BA; Quillo AR; Martin RC; Scoggins CR; Stromberg AJ; McMasters KM
J Am Coll Surg; 2014 Jul; 219(1):101-8. PubMed ID: 24726566
[TBL] [Abstract][Full Text] [Related]
10. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.
Callery C; Cochran AJ; Roe DJ; Rees W; Nathanson SD; Benedetti JK; Elashoff RM; Morton DL
Ann Surg; 1982 Jul; 196(1):69-75. PubMed ID: 7092355
[TBL] [Abstract][Full Text] [Related]
11. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
[TBL] [Abstract][Full Text] [Related]
13. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis.
White RR; Stanley WE; Johnson JL; Tyler DS; Seigler HF
Ann Surg; 2002 Jun; 235(6):879-87. PubMed ID: 12035046
[TBL] [Abstract][Full Text] [Related]
15. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
[TBL] [Abstract][Full Text] [Related]
16. Axillary web syndrome: an underappreciated complication of sentinel node biopsy in melanoma.
Schuitevoerder D; White I; Fortino J; Vetto J
Am J Surg; 2016 May; 211(5):846-9. PubMed ID: 26995594
[TBL] [Abstract][Full Text] [Related]
17. Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease.
van der Ploeg AP; Haydu LE; Spillane AJ; Scolyer RA; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Thompson JF
Ann Surg Oncol; 2014 Sep; 21(9):3108-16. PubMed ID: 24802907
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of clinical stage I melanoma patients with positive elective regional node dissection.
Koh HK; Sober AJ; Day CL; Lew RA; Kopf AW; Lamar W; Ben Cosimi A; Wood WC; Mihm MC; Malt RA
J Clin Oncol; 1986 Aug; 4(8):1238-44. PubMed ID: 3734848
[TBL] [Abstract][Full Text] [Related]
20. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
